Background: Pseudomonas aeruginosa commonly causes nosocomial bloodstream infections and the emergence of a variety of β-lactamases (BLs) is worrying. In 5 hospitals in Belo Horizonte, Brazil, the presence of phenotypes encoding BL genes was established and the genetic diversity of the P. aeruginosa strains recovered from bloodstream infections was analyzed. Materials and Methods: The isolates were investigated using a disk diffusion (DD) method and the Etest®, for encoding metallo-β-lactamases (MBLs), oxacillinases and cephalosporinases. Genes and genetic diversity were evaluated by random amplified polymorphic DNA (RAPD) genotyping and enterobacterial repetitive intergenic consensus (ERIC)-PCR. Results: Twelve strains (30%) were positive for MBLs by Etest and DD, 15 were cephalosporinase-positive and 87.5% were positive for blaSPM-1 and blaVIM-1. Twenty-three strains (57.5%) were grouped into profile A, 32.5% into profile B and 10% into profile C by RAPD genotyping. ERIC-PCR revealed a varying degree of similarity between strains, ranging from 45 to 100%. Conclusions: The results suggest distinct clonal populations in the 5 hospitals studied, indicating a potentially problematic epidemiological situation in Belo Horizonte, Brazil.

Journal Section:
Editor's choice
Keywords:
<italic>Pseudomonas aeruginosa</italic>, Resistance markers, Genetic diversity, Bloodstream infections
1.
Zilberberg MD, Shorr AF: Prevalence of multidrug-resistant Pseudomonasaeruginosa and carbapenem-resistant enterobacteriaceae among specimens from hospitalized patients with pneumonia and bloodstream infections in the United States from 2000 to 2009. J Hosp Med 2013;8:559-563.
https://doi.org/10.1002/jhm.2080
[PubMed]
2.
Walsh TR, Toleman MA, Hryniewicz W, Bennett PM, Jones RN: Evolution of an integron carrying blaVIM-2 in Eastern Europe: report from the SENTRY Antimicrobial Surveillance Program. J Antimicrob Chemother 2003;52:116-119.
[PubMed]
https://doi.org/10.1093/jac/dkg299
3.
Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB,Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL: Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012;18:268-281.
[PubMed]
https://doi.org/10.1111/j.1469-0691.2011.03570.x
4.
Queenan AM, Bush K: Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev 2007;20:440-458.
[PubMed]
https://doi.org/10.1128/CMR.00001-07
5.
Bowers DR, Liew YX, Lye DC, Kwa AL, Hsu LY, Tam VH: Outcomes of appropriate empiric combination versus monotherapy for Pseudomonas aeruginosa bacteremia. Antimicrob Agents Chemother 2013;57;1270-1274.
[PubMed]
https://doi.org/10.1128/AAC.02235-12
6.
Hammami S, Boutiba-Ben Boubaker I, Ghozzi R, Saidani M, Amine S, Ben Redjeb S: Nosocomial outbreak of imipenem-resistant Pseudomonas aeruginosa producing VIM-2 metallo-beta-lactamase in a kidney transplantation unit. Diagn Pathol 2011;6:106.
[PubMed]
https://doi.org/10.1186/1746-1596-6-106
7.
Yan JJ, Hsueh PR, Ko WC, Luh KT, Tsai SH, Wu HM, Wu JJ: Metallo-beta-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme. Antimicrob Agents Chemother 2001;45:2224-2228.
[PubMed]
https://doi.org/10.1128/AAC.45.8.2224-2228.2001
8.
Speijer H, Savelkoul PHM, Bonten MJ, Stobberingh EE, Tjhie JHT: Application of different genotyping methods for Pseudomonas aeruginosa in a setting of endemicity in an intensive care unit. J Clin Microbiol 1999;37:3654-3661.
[PubMed]
9.
Clinical and Laboratory Standards Institute: Performance standards for antimicrobial susceptibility testing, 17th informational supplement, 2011.
10.
Martins HS, Bomfim MRQ, França RO, Farias LM, Carvalho MAR, Serufo JC, Santos SG: Resistance markers and genetic diversity in Acinetobacter baumannii strains recovered from nosocomial bloodstream infections. Int J Environ Res Public Health 2014;11:1465-1478.
[PubMed]
https://doi.org/10.3390/ijerph110201465
11.
Dalmarco EM, Blatt SL, Córdova CMM: Identificação laboratorial de β-lactamases de espectro estendido (ESBLs). Ver Bras Anal Clin 2006;38:171-177.
12.
Lee K, Yum JH, Yong D, Lee HM, Kim HD, Docquier JD, Rossolini GM, Chong Y: Novel acquired metallo-beta-lactamase gene, bla(SIM-1), in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea. Antimicrob Agents Chemother 2005;49:4485-4491.
[PubMed]
https://doi.org/10.1128/AAC.49.11.4485-4491.2005
13.
Coudron PE, Moland ES, Thomson KS: Occurrence and detection of AmpC beta-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center. J Clin Microbiol 2000;38:1791-1796.
[PubMed]
14.
Woodford N, Ellington MJ, Coelho JM, Turton JF, Ward ME, Brown S, Amyes SGB, Livermore DM: Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Ag 2006;27:351-353.
[PubMed]
https://doi.org/10.1016/j.ijantimicag.2006.01.004
15.
Silbert S, Pfaller MA, Hollis RJ, Barth AL, Sader HS: Evaluation of three molecular typing techniques for nonfermentative Gram-negative bacilli. Infect Control Hosp Epidemiol 2004;25:847-851.
[PubMed]
https://doi.org/10.1086/502307
16.
Versalovic J, Koeuth T, Lupski JR: Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes. Nucleic Acids Res 1991;19:6823-6831.
[PubMed]
https://doi.org/10.1093/nar/19.24.6823
17.
Dabrowski W, Czekajlo-Kolodziej U, Medrala D, Giedrys-Kalemba S: Optimisation of AP-PCR fingerprinting discriminatory power for clinical isolates of Pseudomonas aeruginosa. FEMS Microbiol Lett 2003;218:51-57.
[PubMed]
https://doi.org/10.1016/S0378-1097(02)01183-7
18.
Sanguinetti CJ, Dias Neto E, Simpson AJG: Rapid silver staining and recovery of PCR products separated on polyacrylamide gels. Biotech 1994;17:915-918.
[PubMed]
19.
Ribeiro J, Mendes RE, Domingos R, Franca E, Silbert S, Jones RN, Sader HS: Microbiological and epidemiological characterization of imipenem-resistant Pseudomonas aeruginosa strains from a Brazilian tertiary hospital: report from the SENTRY Antimicrobial Surveillance Program. J Chemother 2006;18:461-467.
[PubMed]
https://doi.org/10.1179/joc.2006.18.5.461
20.
Machado GM, Lago A, Fuentefria SR, Fuentefria DB: Occurrence and the susceptibility to antimicrobial agents in Pseudomonas aeruginosa and Acinetobacter sp. at a tertiary hospital in southern Brazil. Rev Soc Bras Med Trop 2011;44:168-172.
[PubMed]
https://doi.org/10.1590/S0037-86822011005000015
21.
Llaca-Díaz JM, Mendonza-Olazarán S, Camacho-Ortiz A, Flores S, Garza-González E: One-year surveillance of ESKAPE pathogens in an intensive care unit in Monterrey, Mexico. Chemotherapy 2012;58:475-481.
[PubMed]
https://doi.org/10.1159/000346352
22.
Cornaglia G, Giamarellou H, Rossolini GM: Metallo-beta-lactamases: a last frontier for beta-lactams? Lancet Infect Dis 2011;11:381-393.
[PubMed]
https://doi.org/10.1016/S1473-3099(11)70056-1
23.
Livermore DM: Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis 2002;34:634-640.
[PubMed]
https://doi.org/10.1086/338782
24.
Falagas ME, Rafailidis PI, Matthaiou DK: Resistance to polymyxins: Mechanisms, frequency and treatment options. Drug Resist Updat 2010;13:132-138.
[PubMed]
https://doi.org/10.1016/j.drup.2010.05.002
25.
Qu T, Zhang J, Wang J,Tao J,Yu Y, Chen Y, Zhou J, Li L: Evaluation of phenotypic tests for detection of metallo-β-lactamase-producing Pseudomonas aeruginosa strains in China. J Clin Microbiol 2009;47:1136-1142.
[PubMed]
https://doi.org/10.1128/JCM.01592-08
26.
Picão RC, Carrara-Marroni FE, Gales AC, Venâncio EJ, Xavier DE, Tognim MC, Pelavo JS: Metallo-β-lactamase-production in meropenem susceptible Pseudomonas aeruginosa isolates: risk for silent spread. Mem Inst Oswaldo Cruz 2012;107:747-751.
[PubMed]
https://doi.org/10.1590/S0074-02762012000600007
27.
Speert DP: Molecular epidemiology of Pseudomonas aeruginosa. Front Biosci 2002;1:354-361.
[PubMed]
https://doi.org/10.2741/speert
28.
Cezario RC, Duarte De Morais L, Ferreira JC, Costa-Pinto RM, da Costa Darini AL, Gontijo-Filho PP: Nosocomial outbreak by imipenem-resistant metallo-beta-lactamase-producing Pseudomonas aeruginosa in an adult intensive care unit in a Brazilian teaching hospital. Enferm Infecc Microbiol Clin 2009;27:269-274.
[PubMed]
https://doi.org/10.1016/j.eimc.2008.09.009
29.
Toleman MA, Simm AM, Murphy TA, Gales AC, Biedenbach DJ, Jones RN, Walsh TR: Molecular characterization of SPM-1, a novel metallo-beta-lactamase isolated in Latin America: report from the SENTRY antimicrobial surveillance programme. J Antimicrob Chemother 2002;50:673-679.
[PubMed]
https://doi.org/10.1093/jac/dkf210
30.
Franco MR, Caiaffa-Filho HH, Burattini MN, Rossi F: Metallo-beta-lactamases among imipenem-resistant Pseudomonas aeruginosa in a Brazilian university hospital. Clinics 2010;65:825-829.
[PubMed]
https://doi.org/10.1590/S1807-59322010000900002
© 2014 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2014
You do not currently have access to this content.